Scheme Meeting Chairmans Address and Presentation
Released
Released
Announcement PDF
ASX ANNOUNCEMENT: 3rd February 2025
Xref Limited (ASX: XF1)
Scheme Meeting Chairman’s Address and Presentation
Xref Limited (ASX: XF1) (Xref or Company) refers to the proposed acquisition of 100% of all the issued shares
in Xref by SEEK International Investments Pty Ltd, a wholly owned subsidiary of SEEK Limited, by way of a
scheme of arrangement for cash consideration of $0.218 per Xref Share (Scheme).
Scheme Meeting
In accordance with ASX Listing Rule 3.13.3, attached to this announcement are the following documents to
be presented at the Scheme Meeting commencing at 4.00pm (AEDT) today:
•
•
the address to be delivered by the Chair of the Scheme Meeting; and
the Scheme Meeting presentation slides.
The Scheme Meeting will be held as a hybrid meeting at Level 10, 2 Park Street, Sydney NSW 2000 and
virtually via Zoom at https://xref.zoom.us/j/91036052627 or by telephone on the numbers found at
https://xref.zoom.us/u/arM3iEXfL.
Further information in relation to the Scheme on how to participate and vote at the Scheme Meeting is set
out in the Notice of Scheme Meeting contained in Annexure D to the Scheme Booklet which is available for
viewing and downloading from Xref’s website at https://www.xf1.com and from the ASX website at
www.asx.com.au (under Xref’s ASX code: XF1).
The voting results of the Scheme Meeting will be communicated to the ASX once available following the
conclusion of the Scheme Meeting.
Further information
If you have any questions in relation to the Scheme or the Scheme Booklet, please contact the Xref
Shareholder Information Line on 1300 429 179 (within Australia) or +61 2 7208 4522 (outside Australia) between
8.30am and 5.30pm (AEDT), Monday to Friday.
This announcement was authorised for release by the Xref Board of Directors.
To learn more or ask questions, please visit;
Website: xref.com
Investor Centre and Presentation: xf1.com
Twitter: @xf1
Xref Limited (ASX:XF1)
ACN 122 404 666
Lv 20, 135 King Street, Sydney, NSW 2000
Phone: +61 2 8244 3099
Website: xref.com
Email: investors@xref.com
1
Xref Limited ABN 34 122 404 666
Scheme Meeting Proceedings
3 February 2025
Xref Limited
Scheme Meeting Proceedings – 3 February 2025
OPENING AND WELCOME
Good afternoon, ladies and gentlemen. My name is Tom Stianos and I am the Chair of
Xref Limited. I extend a warm welcome to our shareholders and those in attendance at
Xref’s Scheme Meeting. This meeting relates to the scheme of arrangement whereby all
of the issued shares in Xref are proposed to be acquired by SEEK Limited’s nominee and
wholly owned subsidiary, SEEK International Investments Pty Ltd. Throughout today’s
Scheme Meeting, I’ll refer to SEEK Limited as ‘SEEK’ and SEEK International Investments
Pty Ltd as the ‘SEEK Nominee’.
Before we start, for those in the room could I please ask you to switch your mobile phone
to silent. Please also note that the use of recording devices during this Scheme Meeting is
not permitted.
HYBRID MEETING
Today’s Scheme Meeting is being held as a hybrid meeting and Xref Shareholders have
been given the opportunity to participate in person or either virtually or by telephone via
Zoom.
VOTING AT THE SCHEME MEETING
Voting on the Scheme Resolution will be conducted on a poll. The poll will open shortly at
the beginning of the Scheme Meeting and will remain open until the close of the meeting.
Xref Shareholders had the option in advance of today's Scheme Meeting to appoint a
proxy. If you did not lodge your Proxy Form and wish to vote on the Scheme Resolution,
you may vote by poll during the meeting. If you are attending virtually or by telephone,
are eligible to vote and wish to vote by poll, you will need to log on to the Automic
meeting platform via your computer, tablet or smartphone and follow the instructions on
screen or on the front page of the Notice of Meeting. Please note, you cannot change
your vote once you have submitted it. If you have any difficulty logging into the Automic
meeting platform, please contact our Share Registry, Automic, on the telephone number
currently on the screen.
Those Xref Shareholders attending in person may also vote, by completing the voting card
you received when registering and lodging it at the end of the meeting. If you have
difficulty completing your voting card, please raise your hand and a representative will
assist you.
Please note that if you cast a live vote at today’s Scheme Meeting any Proxy Form
previously submitted will be overridden.
Prior to putting the Scheme Resolution to the Scheme Meeting, the Scheme Resolution
will be shown on the screen. We will similarly be showing the proxy votes. As Chair, any
undirected proxies I have been given will be voted in the poll in favour of the Scheme
Resolution, as indicated in the Notice of Scheme Meeting. Poll voting will close at the end
of the Scheme Meeting. The poll votes will then be added to the votes completed by
proxy by our Share Registry, Automic, and the results on the voting on the Scheme
Resolution will be released to ASX once available.
P a g e |2
Xref Limited
Scheme Meeting Proceedings – 3 February 2025
Mathew Hunter from Automic is the returning officer for the purposes of conducting and
determining the results of the poll.
QUORUM AND OPENING OF MEETING
We have a quorum of five members for this meeting, as required by Xref’s Constitution, and
I therefore declare the meeting open. I also declare the poll voting open.
INTRODUCTIONS
I now introduce the Founder, Executive Director and Chief Executive Officer (Lee-Martin
Seymour), the Non-Executive Director (Nigel Heap), the Company Secretary (Robert
Waring), the Chief Financial Officer (James Solomons) and the Chief Technology Officer
(Sharon Blesson). We are all available to respond to any questions you may have about
the Scheme in the course of the Scheme Meeting.
QUESTIONS
You may raise questions specific to each item of business by either verbally asking a
question after raising your hand or, if you are joining the Scheme Meeting virtually, by
either pressing the hand icon at the bottom of the screen to verbally ask a question or via
the Q&A section in the Zoom application to type in a question. These questions will be
addressed by me or the relevant person, when considering the Scheme Resolution. Also,
please note for procedural efficiency, questions may be amalgamated together if we
receive multiple questions on one topic. After we have concluded the formal business of
the Scheme Meeting, there will be an opportunity to ask any further questions you may
have about the Scheme.
NOTICE OF SCHEME MEETING TO BE TAKEN AS READ
The Notice of this Scheme Meeting was circulated to Xref Shareholders as required by the
Corporations Act and the ASX Listing Rules. I propose that the Notice of Scheme Meeting
be taken as read, unless there are any objections?
Today's presentation slides were lodged with the ASX this afternoon and are available on
the ASX website.
OVERVIEW OF THE SCHEME
Before moving to our formal business, I would like to say a few words about the proposed
Scheme. Details of the Scheme are also set out in the Scheme Booklet. The Scheme
Booklet remains up-to-date and complete.
As stated in the Scheme Booklet and on screen, the Scheme arose following a Strategic
Review announced by Xref on 21 May 2024, after a number of parties expressed interest
in a potential acquisition of Xref. Following engagement with potential acquirers as part
of the Strategic Review, SEEK was the only party to submit an indicative proposal, which it
did on 20 September 2024.
P a g e |3
Xref Limited
Scheme Meeting Proceedings – 3 February 2025
On 14 November 2024, Xref announced it had entered into a Scheme Implementation
Deed with SEEK under which SEEK agreed that it (or a wholly owned nominee of SEEK)
would acquire all of the issued shares in Xref for cash consideration of $0.218 per Xref
Share.
If the Scheme is approved and implemented, it is intended that Xref Shareholders will
receive cash consideration of $0.218 per Xref Share, which represents:
• a 61% premium to the undisturbed price prior to Xref’s announcement of its
Strategic Review of $0.135 per Xref Share, being the closing share price on 20 May
2024;
• a 61% premium to the closing price on 11 October 2024 (being the last date on
which Xref Shares traded on the ASX prior to the Announcement Date as defined
on screen) of $0.135 per Xref Share;
• a 41% premium to the 30 day volume weighted average price up to and including
11 October 2024 (being the last date on which Xref Shares traded on the ASX prior
to the Announcement Date) of $0.155 per Xref Share;
• a premium to historical share price, as the Scheme Consideration of $0.218 cash
per Xref Share is higher than the Xref closing share price at any time in the 12month period ending 11 October 2024 (the highest price being $0.195 on 6 June
2024); and
• a 4% premium to the closing price on the Last Practicable Date prior to the date of
the Scheme Booklet, being 17 December 2024, which reflects that the market
price of Xref Shares had increased towards the level of the Scheme Consideration
following the Announcement Date.
REASONS WHY YOU MIGHT VOTE FOR OR AGAINST THE SCHEME
The Scheme Booklet sets out various reasons why Xref Shareholders may want to vote in
favour of the Scheme and various reasons why they may want to vote against the
Scheme. These are set out in detail in Section 1 of the Scheme Booklet and are also
displayed on the current slide.
The Scheme Booklet contains further information, including details regarding the risks
associated with the Scheme as well as the risks associated with Xref Shareholders’
continued investment in Xref.
INDEPENDENT EXPERT’S CONCLUSION
The Xref Directors appointed BDO Corporate Finance Australia Pty Ltd as the Independent
Expert to assess the merits of the Scheme. The Independent Expert concluded that the
Scheme is fair and reasonable and in the best interests of Xref Shareholders in the
absence of a Superior Proposal.
A complete copy of the Independent Expert’s Report was attached as Annexure A to the
Scheme Booklet.
BOARD RECOMMENDATION
P a g e |4
Xref Limited
Scheme Meeting Proceedings – 3 February 2025
The Xref Directors unanimously recommend that you vote in favour of the Scheme, in the
absence of a Superior Proposal and subject to the Independent Expert continuing to
conclude that the Scheme is in the best interests of Xref Shareholders.
Prior to this Scheme Meeting, the Xref Directors who hold or control Xref Shares have
given instructions that all of the Xref Shares controlled or held by, or on behalf of, them
be voted in favour of the Scheme in the absence of a Superior Proposal and subject to the
Independent Expert continuing to conclude that the Scheme is in the best interests of
Xref Shareholders.
The Xref Directors confirm that, as at the time of this Scheme Meeting, no Superior
Proposal has emerged nor are they aware of any Superior Proposal likely to emerge.
When considering the Xref Directors’ recommendation, you should have regard to their
interests set out in sections 9.4 and 9.5 of the Scheme Booklet.
STATUS OF CONDITIONS PRECEDENT
The implementation of the Scheme remains subject to the following conditions
precedent:
• approval of the Scheme Resolution by Xref Shareholders at today’s Scheme
Meeting by the Requisite Majorities –which will be determined today; and
• approval of the Scheme by the Supreme Court of New South Wales at the second
Court hearing.
The Scheme is also subject to other customary conditions precedent, which are described
in detail in the Scheme Booklet, noting that the Scheme is not subject to any financing or
due diligence conditions.
As at the time of today’s meeting, the Xref Directors are not aware of any circumstances
which would cause any of these other outstanding conditions not to be satisfied (or
waived, if applicable).
TIMETABLE TO IMPLEMENTATION
I will now turn to the proposed timetable for implementation of the Scheme.
If the Scheme is approved by the Requisite Majorities of Xref Shareholders at this Scheme
Meeting, Xref expects to take the Scheme to the Supreme Court of New South Wales for
approval at 3:00pm on Monday, 10 February 2025.
If the Court approves the Scheme, a copy of the Court orders approving the Scheme is
expected to be lodged with the Australian Securities and Investments Commission on
Tuesday, 11 February 2025 (which would be when the Scheme becomes Effective). It is
expected that Xref Shares will be suspended from trading on the ASX at the close of
trading on that date.
If the Scheme becomes Effective, Xref Shareholders on the register at 5:00pm on
Thursday, 13 February 2025 will be entitled to receive the Scheme Consideration of
$0.218 for each Xref Share they hold on that date.
P a g e |5
Xref Limited
Scheme Meeting Proceedings – 3 February 2025
Payment of the Scheme Consideration will be made on the Implementation Date, which is
expected to be Thursday, 20 February 2025. If you have not yet nominated a bank
account through Automic’s website, we strongly recommend you do as soon as possible.
See the Scheme Booklet for further instructions.
SCHEME RESOLUTION
We will now move to the formal business of this Scheme Meeting.
To consider, and if thought fit, to pass, with or without amendment, the following
resolution in accordance with section 411(a)(ii) of the Corporations Act:
“That pursuant to and in accordance with section 411 of the Corporations Act, the
Scheme, the terms of which are contained in and more particularly described in the
Scheme Booklet of which this Notice of Scheme Meeting forms part, is approved (with or
without modifications, alterations or conditions as approved by the Court and agreed to
by Xref and SEEK in writing) and, subject to approval of the Scheme by the Court, the Xref
Board is authorised to implement the Scheme with any such modifications, alterations or
conditions.”
VOTING THRESHOLD
In order for the Scheme Resolution to be passed, it must be approved by the Requisite
Majorities being:
•
•
unless the Court determines otherwise, a majority in number (i.e. more than 50%)
of Xref Shareholders present and voting at this Scheme Meeting (whether in
person, virtually, by proxy, by attorney or by a corporate representative); and
at least 75% of the total number of votes cast on the Scheme Resolution by Xref
Shareholders present and voting at the Scheme Meeting (whether in person,
virtually, by proxy, corporate representative or attorney).
QUESTIONS AND COMMENTS
I now offer Xref Shareholders the opportunity to ask any questions they may have about
the Scheme.
VOTING
Any Xref Shareholders who have not voted, are reminded to do so now, as voting will be
closing shortly. I now invite Mathew Hunter, from Automic, to collect your voting cards.
PROXY RESULTS
While you are finalising your votes, I will read out details of proxies received.
The proxy votes received in respect of the Scheme Resolution are now shown on the
screen as follows:
P a g e |6
Xref Limited
Scheme Meeting Proceedings – 3 February 2025
•
90,415,439 proxy votes in favour from 54 Xref Shareholders, representing 62.65%
of the proxy votes and 70.13% of the number of Xref Shareholders voting by
proxy;
•
19,435,697 proxy votes undirected from 7 Xref Shareholders, representing 13.47%
of the proxy votes and 9.09% of the number of Xref Shareholders voting, with
34,710 being held by me as Chair which I will vote in favour of the Scheme
Resolution; and
•
34,466,501 proxy votes against from 17 Xref Shareholders, representing 23.88% of
the proxy votes and 22.08% of the number of Xref Shareholders voting by proxy.
FINAL REMARKS
Automic will collate and process the votes submitted by poll shortly. Voting results for
the Scheme Resolution addressed in this Scheme Meeting will be finalised after the close
of this Scheme Meeting and will be announced on the ASX platform once available.
Please complete your poll voting, which will be closing soon.
CLOSURE
As there is no further business, if there are no more questions or comments, I will now
proceed to close this Scheme Meeting.
I declare that voting by poll is now closed.
I thank you all for your attendance today and for your continued support of Xref. I now
formally declare this Scheme Meeting closed.
P a g e |7
(ASX: XF1)
Scheme Meeting
SCHEME RESOLUTION
For poll voting, if you have any difficulty logging
into the Automic Meeting Platform, please
contact our Share Register, Automic, on 1300 816
159 (within Australia) or +61 2 8072 1479 (outside of
Australia).
Xref Limited ABN 34 122 404 666
Voting instructions
To contact support:
Please call 1300 816 159
(within Australia) or
+61 2 8072 1479 (outside of
Australia)
2
1
Go to
https://investor.automic.c
om.au/#/home
2
Once logged in you will
see that the meeting is
open for registration.
Click on “view”
3
Click on “register” to
register your attendance
for the meeting
Voting instructions (continued)
To contact support:
Please call 1300 816 159
(within Australia) or
+61 2 8072 1479
(outside of Australia)
3
4
Once the Chair of the
Meeting declares voting
open, you should select
“refresh”
5
To vote, simply select the
direction in which you
would like to cast your
vote. The selected option
will change colour.
6
Once voting is declared
closed you must select
“next” and then “confirm”
to submit your vote.
Overview of Scheme
• On 21 May 2024, following several parties expressing interest in a potential acquisition of Xref, Xref announced a Strategic Review of
its business. The review culminated in Xref receiving a non-binding and confidential proposal from SEEK Limited (SEEK) on 20
September 2024 to acquire 100% of Xref at $0.218 in cash per Xref Share (Scheme Consideration).
• On 14 October 2024, Xref announced its entry into an exclusivity deed with SEEK and receipt of SEEK’s non-binding and confidential
proposal (Announcement Date) and on 14 November 2024, Xref announced its entry into a Scheme Implementation Deed with
SEEK, under which SEEK (or a nominee wholly owned by SEEK) would acquire 100% of the Xref Shares on issue, by way of a scheme
of arrangement.
• If the Scheme is approved and implemented, it is intended that Xref Shareholders will receive the Scheme Consideration, which
implies an equity value of approximately $41.85 million and represents:
o a 61% premium to the undisturbed price prior to Xref’s announcement of its Strategic Review of $0.135 per Xref Share, being
the closing share price on 20 May 2024;
o a 61% premium to the closing price on 11 October 2024 (being the last date on which Xref Shares traded on the ASX prior to
the Announcement Date) of $0.135 per Xref Share;
o a 41% premium to the 30 day volume weighted average price (VWAP) up to and including 11 October 2024 (being the last
date on which Xref Shares traded on the ASX prior to the Announcement Date) of $0.155 per Xref Share;
o a premium to historical share price, as the Scheme Consideration of $0.218 cash per Xref Share is higher than the Xref closing
share price at any time in the 12-month period ending 11 October 2024 (the highest price being $0.195 on 6 June 2024); and
o a 4% premium to the closing price on the Last Practicable Date (being 17 December 2024), which reflects that the market
price of Xref Shares has increased towards the level of the Scheme Consideration following the Announcement Date.
4
Reasons to vote for or against the Scheme
Reasons why you may consider voting For
ü Your Xref Directors unanimously recommend that you vote in favour of the Scheme, in the absence of a Superior Proposal (as defined in the
Scheme Booklet) and subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of Xref Shareholders.
ü The Independent Expert has concluded that the Scheme is fair and reasonable and in the best interests of Xref Shareholders in the absence of a
Superior Proposal.
ü The Scheme Consideration of $0.218 cash per Xref Share represents a significant premium for your Xref Shares.
ü The all cash consideration provides Xref Shareholders with certainty of value and will avoid ongoing risks and uncertainties associated with Xref’s
business.
ü The Scheme has limited and customary conditionality.
ü Since the announcements of the Strategic Review and Scheme, no Superior Proposal has emerged and the Xref Directors are unaware of any
potential Superior Proposal.
ü If the Scheme is not implemented and in the absence of a Superior Proposal, Xref’s share price may continue to be subject to market volatility
and the Xref Directors are of the opinion that the price of an Xref Share on the ASX may fall in the short term.
ü You will not incur any brokerage charges on the transfer of your Xref Shares if the Scheme proceeds.
Note: when considering the Xref Directors’ recommendation, be aware that Lee-Martin Seymour, a director and CEO of Xref, will be receiving a benefit if the Scheme or a Superior Proposal is
completed. Mr Seymour is eligible for a retention payment of $130,000 as described in section 9.5(b) of the Scheme Booklet. Despite this interest in the outcome of the Scheme, Mr Seymour
considers that, given the importance of the Scheme, and his role as CEO of Xref it is important and appropriate for him to provide a recommendation to Xref Shareholders in relation to voting
on the Scheme. Additionally, the Xref Board (excluding Mr Seymour) also considers that it is appropriate for Mr Seymour to make a recommendation on the Scheme given his role in the
management and operations of Xref. You should also note, the interests of each Xref Director in securities in Xref as set out in Section 9.4 of the Scheme Booklet.
Reasons why you may consider voting Against
You may disagree with the Xref Directors’ unanimous recommendation and the Independent Expert’s conclusion.
You may prefer to participate in the future financial performance of the Xref business or assets.
You may believe it is in your best interests to maintain your current investment and risk profile.
The tax consequences of the Scheme may not be attractive to you.
You may believe that there is potential for a Superior Proposal to emerge in the foreseeable future despite the Strategic Review only resulting in a
non-binding
and confidential proposal from SEEK.
5
Independent Expert’s conclusion & Board recommendation
Independent Expert’s Conclusion
• The Xref Directors appointed BDO Corporate Finance Australia Pty Ltd as the Independent Expert to assess the merits of the Scheme.
• The Independent Expert concluded that the Scheme is fair and reasonable and in the best interests of Xref Shareholders in the
absence of a Superior Proposal.
• A complete copy of the Independent Expert’s Report was attached as Annexure A to the Scheme Booklet.
Board Recommendation
• The Xref Directors unanimously recommend that you vote in favour of the Scheme, in the absence of a Superior Proposal and subject
to the Independent Expert continuing to conclude that the Scheme is in the best interests of Xref Shareholders.
• Prior to this Scheme Meeting, the Xref Directors who hold or control Xref Shares have instructed that all of the Xref shares controlled or
held by, or on behalf of, them be voted in favour of the Scheme in the absence of a Superior Proposal and subject to the
Independent Expert continuing to conclude that the Scheme is in the best interests of Xref Shareholders.
• The Xref Directors confirm that, as at the time of this Scheme Meeting, no Superior Proposal has emerged nor are they aware of any
Superior Proposal likely to emerge.
Note: when considering the Xref Directors’ recommendation, be aware that Lee-Martin Seymour, a director and CEO of Xref, will be receiving a benefit if the Scheme or a Superior Proposal is
completed. Mr Seymour is eligible for a retention payment of $130,000 as described in section 9.5(b) of the Scheme Booklet. Despite this interest in the outcome of the Scheme, Mr Seymour
considers that, given the importance of the Scheme, and his role as CEO of Xref it is important and appropriate for him to provide a recommendation to Xref Shareholders in relation to voting
on the Scheme. Additionally, the Xref Board (excluding Mr Seymour) also considers that it is appropriate for Mr Seymour to make a recommendation on the Scheme given his role in the
management and operations of Xref. You should also note, the interests of each Xref Director in securities in Xref as set out in Section 9.4 of the Scheme Booklet.
6
Status of the conditions precedent
Implementation of the Scheme remains subject to the following conditions precedent:
• approval of the Scheme Resolution by Xref Shareholders at today’s Scheme Meeting by the Requisite Majorities (as defined in the
Scheme Booklet) – which will be determined today; and
• approval of the Scheme by the Supreme Court of New South Wales at the second Court hearing.
The Scheme is also subject to other customary conditions precedents, which are described in detail in the Scheme Booklet, noting that
the Scheme is not subject to any financing or due diligence conditions.
7
Indicative implementation timetable
Event
Date and Time *
Scheme Meeting
Monday, 3 February 2025 at
4.00pm
Second Court Hearing: For the approval of the Scheme.
Monday, 10 February 2025 at
3:00pm
Effective Date: The date on which the Scheme becomes Effective and is binding on Xref
Shareholders. Lodgement by Xref with ASIC of the Court orders approving the Scheme. Last
day of trading in Xref Shares on ASX.
Tuesday, 11 February 2025
Scheme Record Date: Time and date for determining entitlements to the Scheme
Consideration.
Thursday, 13 February 2025 at
5.00pm
Implementation Date: The date on which the Scheme will be implemented, and Scheme
Consideration will be paid to Xref Shareholders.
Thursday, 20 February 2025
* All stated dates and times are references to the date and time in Sydney, New South Wales.
8
Scheme Resolution and voting thresholds
To consider and, if thought fit, to pass, with or without amendment, the following resolution in accordance with
section 411(4)(a)(ii) of the Corporations Act:
“That pursuant to and in accordance with section 411 of the Corporations Act, the Scheme, the terms of which are contained in and
more particularly described in the Scheme Booklet of which this Notice of Scheme Meeting forms part, is approved (with or without
modifications, alterations or conditions as approved by the Court and agreed to by Xref and SEEK in writing) and, subject to approval of
the Scheme by the Court, the Xref Board is authorised to implement the Scheme with any such modifications, alterations or conditions.”
For the Scheme to proceed, it must be approved by the Requisite Majorities being:
• unless the Court determines otherwise, a majority in number (i.e. more than 50%) of Xref Shareholders present and voting at this
Scheme Meeting (whether in person, virtually, by proxy, by attorney or by a corporate representative); and
• at least 75% of the total number of votes cast on the Scheme Resolution by Xref Shareholders present and voting at the Scheme
Meeting (whether in person, virtually, by proxy, corporate representative or attorney).
9
Questions
The Chair will call for any questions from Xref Shareholders
Xref Limited ABN 34 122 404 666
Proxy results
Number of votes cast
% of votes cast
Number of Shareholders
% of Shareholders
For
90,415,439
62.65
54
70.13
Against
34,466,501
23.88
17
22.08
Discretionary
19,435,697
13.47
7
9.09
Total*
144,317,637
100.00
77
100
Abstain
0
0
0
0
Requisite Majorities
At least 75%
More than 50%
* Due to split voting, Total reflects the total number of voting shareholders but is not the sum of the number of shareholders voting “For”, “Against” and “Discretionary”.
11
Closure of
Scheme Meeting
xref.com | Xf1.com
Share your feedback
Discover